What does it matter if the SAR SP retraces at periods between news . It has been doing that for years and will no doubt continue to do so at least until the next RNS. A very long day , week , month ahead for those who continue peer into this board trying to puff the SP up every 5 minutes. Be patient , if you believe in the company get a feel for the situation then take advantage of the dips for a top up and also sell a few into any rise. It might make what could be a long month a head a little more interesting.
In several of today's 'broadsheets' it is rumoured that Novartis are 'stalking' Astra Zeneca with a view to a full-blown acquisition of the Company and in so doing, view AZN's imuno-oncology development pipeline as the "jewel in the crown"
I'm not sure that this week's new publication takes us any further, as they are basically test tube results. Sure, they show useful effects, but the key factor with these drugs is toxicity rather than efficacy, and you cannot really judge human toxicity in a test tube (or a mouse). So the really important results will be the ones from the c.linical trial now starting. Nevertheless, it looks more and more likely that there will be a deal done here.
Just to let you know that trade was actually mine and I can confirm it was a buy! Quite exciting to have the biggest trade, although it is a fairly modest one. Surely there must be bigger buyers out there?
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.